Raman Singh has sold LQDA and made no open-market buys since Mar 2026

Raman Singh is a biopharmaceutical executive and board director who serves as an Independent Director of Liquidia Corp., where he has been a member of the Board, Audit Committee, and Nominating and Corporate Governance Committee since the company’s formation as Liquidia Corporation.( As a Liquidia insider, he has reported multiple equity transactions in the company’s stock, including option exercises and share sales while retaining a significant beneficial ownership stake.( In addition to his board role at Liquidia, Singh is the founder and Co‑Chief Executive Officer of Juniper Biologics Pte Ltd, a position he has held since 2020.(

Singh’s career spans senior leadership roles in global pharmaceutical and healthcare companies, including service as Chief Executive Officer of Mundipharma Pte Ltd. (2011–2020), Regional Director at Abbott in Australia and New Zealand, General Manager at Abbott Korea, and Vice President of Commercial Operations at GSK plc.( He holds an undergraduate degree from Osmania University (1992), an MBA from Assumption University, and a graduate degree from the Thunderbird School of Global Management, reflecting a formal academic background in business and global management that supports his work leading and advising healthcare and biopharma organizations.(

Written by Perplexity from public sources.